TrialThe New England journal of medicine2019
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.
NAMSAL ANRS 12313 Study Group et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
189 papers cite itlatest 60 shown
this paperpooled ittrialcites it